Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
This bridges to the BALANCE Model, which will expand comprehensive Medicare Part D coverage for obesity treatments from January 1, 2027
The insurer reviews eligibility, medical necessity, and supporting records
OFA is also seeking a temporary restraining order (TRO) that would enjoin FDA from taking action against OFAs members for making compounded versions of tirzepatide during the pendency of the lawsuit
It is prescribed by licensed healthcare providers only when commercially available alternatives are not suitable
Suppliers use the two labels interchangeably
US$ 28.55
US$ 27.97
US$ 25.09
US$ 21.61
US$ 29.00
US$ 24.17
US$ 28.34
US$ 28.67
US$ 27.06
